Agilent Technologies Launches Dako Omnis Family at European Congress of Pathology 2025

What's Happening?

Agilent Technologies Inc., a leader in analytical and clinical laboratory technologies, has announced its participation as a premium sponsor at the European Congress of Pathology (ECP) 2025 in Vienna, Austria. The company will introduce its newly expanded Dako Omnis Family of instruments, including the Dako Omnis 110, 165, and 165 Duo models. These instruments are designed to enhance flexibility, consistency, and efficiency in pathology labs of various sizes. Agilent aims to address the evolving needs of modern pathology labs with these high-performance diagnostic solutions, supported by dedicated service and support teams. The launch is part of Agilent's commitment to delivering scalable solutions that empower labs to meet increasing demands confidently.

Why It's Important?

The introduction of the Dako Omnis Family by Agilent Technologies is significant for the pathology industry, as it promises to improve diagnostic accuracy and operational efficiency in labs. This development is crucial for healthcare providers who rely on precise and timely diagnoses to inform treatment decisions. By offering advanced instruments that cater to the diverse needs of pathology labs, Agilent is positioning itself as a key player in the diagnostic market. The company's focus on supporting diagnostic excellence aligns with the growing demand for reliable and scalable solutions in the healthcare sector, potentially benefiting both patients and medical professionals.

What's Next?

Agilent's participation in the European Congress of Pathology 2025 will include live demonstrations of the Dako Omnis Family, expert sessions, and educational symposia. These activities are designed to engage attendees and showcase the capabilities of the new instruments. The company will also present its end-to-end Digital Pathology solutions and conduct PD-L1 CPS scoring sessions. These initiatives are expected to enhance Agilent's visibility in the pathology community and foster collaborations with industry experts. The successful launch and reception of the Dako Omnis Family could lead to further innovations and expansions in Agilent's product offerings.